✨
Yapay Zeka Hızlı Bakış & Çıkarımlar
AI Insight⚡ TL;DR(1 Cümlede Hızlı Çıkarım)
Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalazine therapy for ulcerative colitis in a patient under long-term follow-up in our clinic due to chronic obstructive pulmonary disease.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Sulfasalazine has been used in the treatment of inflammatory bowel disease for over 60 years.
📊
Temel Bulgular & Veri:Although the drug is frequently associated with gastrointestinal adverse effects, pulmonary adverse effects are very rare.
💡
Sonuç & Katkı:Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalazine therapy for ulcerative colitis in a patient under long-term follow-up in our clinic due to chronic obstructive pulmonary disease.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Sulfasalazine has been used in the treatment of inflammatory bowel disease for over 60 years. Although the drug is frequently associated with gastrointestinal adverse effects, pulmonary adverse effects are very rare. Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalazine therapy for ulcerative colitis in a patient under long-term follow-up in our clinic due to chronic obstructive pulmonary disease.
🔖
Bu Makaleye Atıf Yap
SAĞLAM, L., ARAZ, Ö., AKGÜN, M., UÇAR, E. Y., AYDIN, Ö., KERGET, B. (2022). Sulfasalazine-Induced Interstitial Fibrosis. Eurasian Journal of Medicine, Cilt: 50 - Sayı: 3, 207–209. https://ajindex.com/articles/508969